Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology

M. Axelstad; Ulla Hass; I. Bichlmaier; U. Simanainen; C. Beausoleil; J. Deweirdt; C. Bergkvist; S. Christiansen

doi:10.1016/j.toxlet.2024.07.889

Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology

M. Axelstad^*
, Ulla Hass
, I. Bichlmaier
, U. Simanainen
, C. Beausoleil
, J. Deweirdt
, C. Bergkvist
, S. Christiansen

^*Corresponding author for this work

European Chemicals Agency
Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail
Swedish Chemicals Agency

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	LP-26
Journal	Toxicology Letters
Volume	399
Issue number	Supplement 2
Pages (from-to)	S374
Number of pages	1
ISSN	0378-4274
DOIs	https://doi.org/10.1016/j.toxlet.2024.07.889
Publication status	Published - 2024
Event	58th Congress of the European Societies of Toxicology - Copenhagen, Denmark Duration: 8 Sept 2024 → 11 Sept 2024

Conference

Conference	58th Congress of the European Societies of Toxicology
Country/Territory	Denmark
City	Copenhagen
Period	08/09/2024 → 11/09/2024

Access to Document

10.1016/j.toxlet.2024.07.889

OpenUrl availability

Check availability in DTU Findit

Cite this

Axelstad, M., Hass, U., Bichlmaier, I., Simanainen, U., Beausoleil, C., Deweirdt, J., Bergkvist, C., & Christiansen, S. (2024). Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology. Toxicology Letters, 399(Supplement 2), S374. Article LP-26. https://doi.org/10.1016/j.toxlet.2024.07.889

@article{9b384eef9a334ac1b08529528c6dcc76,

title = "Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology",

author = "M. Axelstad and Ulla Hass and I. Bichlmaier and U. Simanainen and C. Beausoleil and J. Deweirdt and C. Bergkvist and S. Christiansen",

year = "2024",

doi = "10.1016/j.toxlet.2024.07.889",

language = "English",

volume = "399",

pages = "S374",

journal = "Toxicology Letters",

issn = "0378-4274",

publisher = "Elsevier Ireland Ltd",

number = "Supplement 2",

note = "58th Congress of the European Societies of Toxicology, EUROTOX 2024 ; Conference date: 08-09-2024 Through 11-09-2024",

}

Axelstad, M , Hass, U, Bichlmaier, I, Simanainen, U, Beausoleil, C, Deweirdt, J, Bergkvist, C & Christiansen, S 2024, 'Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology', Toxicology Letters, vol. 399, no. Supplement 2, LP-26, pp. S374. https://doi.org/10.1016/j.toxlet.2024.07.889

Revealing hidden challenges: an in-depth evaluation of Anogenital Distance (AGD) and Areola/Nipple Retention (NR) assessments in EOGRT Studies, with implications for regulatory toxicology. / Axelstad, M.; Hass, Ulla; Bichlmaier, I. et al.
In: Toxicology Letters, Vol. 399, No. Supplement 2, LP-26, 2024, p. S374.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Revealing hidden challenges

T2 - 58th Congress of the European Societies of Toxicology

AU - Axelstad, M.

AU - Hass, Ulla

AU - Bichlmaier, I.

AU - Simanainen, U.

AU - Beausoleil, C.

AU - Deweirdt, J.

AU - Bergkvist, C.

AU - Christiansen, S.

PY - 2024

Y1 - 2024

U2 - 10.1016/j.toxlet.2024.07.889

DO - 10.1016/j.toxlet.2024.07.889

M3 - Conference abstract in journal

SN - 0378-4274

VL - 399

SP - S374

JO - Toxicology Letters

JF - Toxicology Letters

IS - Supplement 2

M1 - LP-26

Y2 - 8 September 2024 through 11 September 2024

ER -